Blue Trust Inc. Acquires 204 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Blue Trust Inc. raised its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 234.5% during the 3rd quarter, Holdings Channel reports. The fund owned 291 shares of the biotechnology company’s stock after purchasing an additional 204 shares during the period. Blue Trust Inc.’s holdings in Axon Enterprise were worth $116,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in AXON. Brookstone Capital Management lifted its position in Axon Enterprise by 5.1% during the first quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after acquiring an additional 41 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Axon Enterprise by 4.4% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 7,519 shares of the biotechnology company’s stock worth $2,353,000 after purchasing an additional 319 shares in the last quarter. Hennion & Walsh Asset Management Inc. purchased a new position in Axon Enterprise during the 1st quarter worth $392,000. SteelPeak Wealth LLC purchased a new stake in Axon Enterprise in the first quarter valued at about $209,000. Finally, Diversified Trust Co boosted its holdings in Axon Enterprise by 61.3% in the first quarter. Diversified Trust Co now owns 2,140 shares of the biotechnology company’s stock worth $670,000 after acquiring an additional 813 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Up 0.1 %

Axon Enterprise stock opened at $444.77 on Tuesday. The business’s 50-day moving average price is $397.53 and its 200 day moving average price is $337.50. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. The firm has a market cap of $33.57 billion, a price-to-earnings ratio of 130.05, a price-to-earnings-growth ratio of 11.91 and a beta of 0.94. Axon Enterprise, Inc. has a 52 week low of $199.50 and a 52 week high of $455.17.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business had revenue of $504.00 million for the quarter, compared to analysts’ expectations of $478.35 million. During the same quarter last year, the company earned $0.80 EPS. The business’s revenue was up 34.5% on a year-over-year basis. As a group, sell-side analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Bank of America started coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective for the company. Barclays lifted their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Jefferies Financial Group started coverage on Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price on the stock. Craig Hallum lifted their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Finally, The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $382.85.

Insider Buying and Selling at Axon Enterprise

In related news, President Joshua Isner sold 25,811 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the transaction, the president now owns 228,166 shares of the company’s stock, valued at approximately $82,103,253.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, insider Jeffrey C. Kunins sold 8,182 shares of the firm’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $364.86, for a total value of $2,985,284.52. Following the transaction, the insider now directly owns 176,228 shares of the company’s stock, valued at approximately $64,298,548.08. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total value of $9,287,830.24. Following the sale, the president now owns 228,166 shares of the company’s stock, valued at approximately $82,103,253.44. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 371,172 shares of company stock valued at $137,000,162. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.